Renaud L, Wencel J, Pagès A, Al Jijakli A, Moatti H, Quero L, Camus V, Brice P. Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma. Haematologica 2024;109(9):3019-3023; https://doi.org/10.3324/haematol.2023.284689.